Long intergenic non-protein coding RNA 2217 (LINC02217)

Long intergenic non-protein coding RNA 2217 (LINC02217) is a human long intergenic non-coding RNA (lincRNA), annotated with the symbol LINC02217[3]. LincRNAs are defined as non-coding RNA transcripts longer than 200 nucleotides that do not overlap protein-coding genes and are autonomously transcribed[1]. They participate in a wide variety of cellular processes, primarily through regulation of gene expression—including scaffolding chromatin modifying complexes, modulating chromatin structure, influencing transcriptional regulation, acting as RNA scaffolds for protein complexes, and stabilizing target RNAs[1][5]. LincRNAs have been shown to have highly tissue-specific expression patterns and can act through both sequence-dependent and sequence-independent mechanisms[1]. While many lincRNAs have been implicated in disease (notably in gene regulatory networks relevant to cancer, neurological, or cardiovascular disorders), there are no reported drug interactions nor evidence that LINC02217 itself serves as a current therapeutic target or clinically actionable biomarker[3][1][5]. Note: The above fields return null where specific information about LINC02217 is not available or is not established in current literature. Functions and roles attributed are based on the general properties of the lincRNA family[1][5].

Other names

LINC02217